Immunovant, Inc. (IMVT) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Roivant Sciences Ltd. 113,317,007 주 보유. 기타 주요 보유자에는 Health Sciences Holdings, LLC 및 Salzmann Peter.
지난 12개월간 내부자는 30 건의 거래를 수행 IMVT 주식 — 5 건 매수 (평가액 $353.18M) 및 21 건 매도 (평가액 $937.25K). 내부자 매도가 매수를 초과했습니다.
IMVT 내부자 보유 현황
최대 보유자
Roivant Sciences Ltd.
113,317,007 주
매도 (12개월)
21
$937.25K 평가액
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Roivant Sciences Ltd. |
10 Percent Owner |
113,317,007 |
2025-12-12 |
|
| 2 |
Health Sciences Holdings, Llc |
10 Percent Owner |
10,000,000 |
2019-05-15 |
|
| 3 |
Salzmann Peter |
Chief Executive Officer |
1,178,191 |
2025-04-17 |
|
| 4 |
Wong Roderick |
Chief Executive Officer |
902,498 |
2019-12-13 |
|
| 5 |
Butchko Julia G. |
Chief Development Officer |
440,959 |
2024-08-23 |
|
| 6 |
Barnett Eva Renee |
Chief Financial Officer |
396,774 |
2025-04-17 |
|
| 7 |
Zeldin Robert K |
Chief Medical Officer |
380,325 |
2019-12-20 |
|
| 8 |
Macias William L. |
Chief Medical Officer |
357,353 |
2025-02-21 |
|
| 9 |
Levine Mark S. |
Chief Legal Officer |
319,228 |
2024-11-22 |
|
| 10 |
Geffner Michael |
Chief Medical Officer |
217,958 |
2025-10-24 |
|
| 11 |
Girao Tiago |
Chief Financial Officer |
208,388 |
2025-05-05 |
|
| 12 |
Stout Jay S |
Chief Technology Officer |
197,634 |
2026-01-23 |
|
| 13 |
Gloria Melanie |
Chief Operating Officer |
170,273 |
2026-02-27 |
|
| 14 |
Van Tuyl Christopher |
Chief Legal Officer |
147,053 |
2026-03-20 |
|
| 15 |
Middlekauff W Bradford |
General Counsel |
142,600 |
2020-05-18 |
|
| 16 |
Hughes Douglas J. |
Director |
120,773 |
2025-12-03 |
|
| 17 |
Jain Rita |
Chief Medical Officer |
117,600 |
2021-03-31 |
|
| 18 |
Elliott Michael James |
Chief Scientific Officer |
97,600 |
2021-03-23 |
|
| 19 |
Torti Frank |
Director |
93,599 |
2025-04-03 |
|
| 20 |
Fromkin Andrew J. |
Director |
85,852 |
2025-12-03 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-04-02 |
Venker Eric |
Chief Executive Officer |
정보 매도 |
1,409 |
$24.60 |
$34.66K |
| 2026-04-01 |
Venker Eric |
Chief Executive Officer |
주식 반환 |
334,960 |
$25.10 |
$8.41M |
| 2026-03-18 |
Van Tuyl Christopher |
Chief Legal Officer |
정보 매도 |
2,877 |
$24.97 |
$71.84K |
| 2026-02-25 |
Gloria Melanie |
Chief Operating Officer |
정보 매도 |
942 |
$28.90 |
$27.22K |
| 2026-01-21 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
1,977 |
$26.03 |
$51.46K |
| 2026-01-07 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
55 |
$26.92 |
$1.48K |
| 2025-12-18 |
Van Tuyl Christopher |
Chief Legal Officer |
정보 매도 |
2,284 |
$27.38 |
$62.54K |
| 2025-12-12 |
Roivant Sciences Ltd. |
10 Percent Owner |
정보 매수 |
16,666,666 |
$21.00 |
$350M |
| 2025-12-01 |
Hughes Douglas J. |
Director |
정보 매도 |
1,909 |
$23.96 |
$45.74K |
| 2025-12-01 |
Fromkin Andrew J. |
Director |
정보 매도 |
2,898 |
$23.95 |
$69.41K |
| 2025-11-20 |
Gloria Melanie |
Chief Operating Officer |
정보 매도 |
2,375 |
$23.97 |
$56.93K |
| 2025-10-22 |
Geffner Michael |
Chief Medical Officer |
정보 매도 |
2,595 |
$19.03 |
$49.38K |
| 2025-10-22 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
2,520 |
$19.03 |
$47.96K |
| 2025-10-08 |
Geffner Michael |
Chief Medical Officer |
정보 매도 |
1,272 |
$16.30 |
$20.73K |
| 2025-10-08 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
1,585 |
$16.30 |
$25.84K |
| 2025-07-28 |
Venker Eric |
Chief Executive Officer |
RSU 부여 |
189,900 |
$16.76 |
$3.18M |
| 2025-07-23 |
Geffner Michael |
Chief Medical Officer |
정보 매도 |
2,385 |
$18.15 |
$43.29K |
| 2025-07-23 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
2,805 |
$18.15 |
$50.91K |
| 2025-07-09 |
Geffner Michael |
Chief Medical Officer |
정보 매도 |
1,160 |
$17.24 |
$20K |
| 2025-07-09 |
Stout Jay S |
Chief Technology Officer |
정보 매도 |
1,519 |
$17.24 |
$26.19K |
| 2025-05-01 |
Susman Robert Graham |
Director |
RSU 부여 |
25,016 |
- |
- |
| 2025-05-01 |
Bauer Jake |
Director |
RSU 부여 |
25,016 |
- |
- |
| 2025-05-01 |
Girao Tiago |
Chief Financial Officer |
RSU 부여 |
208,388 |
- |
- |
| 2025-04-18 |
Susman Robert Graham |
Officer |
알 수 없음 |
- |
- |
- |
| 2025-04-18 |
Bauer Jake |
Officer |
알 수 없음 |
- |
- |
- |
